東莨菪鹼市場：按類型、管理方法分類 - 全球預測 2025-2030

2023年東莨菪鹼市值為4.3916億美元，預計到2024年將達到4.6041億美元，複合年成長率為4.66%，預計到2030年將達到6.0428億美元。

東莨菪鹼，也稱為東莨菪鹼，是一種生物鹼藥物，主要用於治療暈動病和術後噁心和嘔吐。作為抗膽鹼能藥物，阻斷中樞和周圍神經系統中的神經傳導物質乙醯膽鹼。對東莨菪鹼的需求源於其預防噁心的作用，其應用範圍擴展到大腸激躁症和肌肉痙攣等其他疾病的治療，這說明了其在製藥業的多方面應用。最常見的是經皮吸收貼片、口服錠劑和靜脈注射劑，它們廣泛用於臨床環境、非處方藥和急診醫學。東莨菪鹼市場受到旅行活動增加導致暈車盛行率增加、胃腸道治療應用擴大以及神經退化性疾病治療持續研究等因素的顯著影響。還有機會擴大在動物用藥品的應用並開發新的給藥方法以提高療效並減少副作用。為了抓住這些機會，建議投資先進的研發以及與旅遊產業相關人員的合作，從而提高產品的知名度和接受度。然而，法律規範、抗膽鹼能藥物通用的副作用（如口乾、嗜睡和視力模糊）以及來自替代療法的競爭等因素正在阻礙成長。技術創新的重點可能是開發更具選擇性的東莨菪鹼衍生物，減少副作用，並探索在阿茲海默症認知障礙中的潛在應用。儘管市場競爭激烈，但在新興國家不斷擴大的治療應用和不斷成長的需求的推動下，這是一個充滿前景的市場。公司需要根據消費者需求和監管環境調整策略，以最大限度地發揮市場潛力。

市場動態：揭示快速發展的東莨菪鹼市場的關鍵市場洞察

供應和需求的動態交互作用正在改變東莨菪市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

• 市場促進因素
  • 人們越來越認知到使用東莨菪鹼作為暈動病藥物
  • 旅客數量和國際觀光的增加
  • 東莨菪鹼作為非處方藥的可用性
• 市場限制因素
  • 高成本和嚴格的監管通訊協定
• 市場機會
  • 在手術和術後恢復中增加經皮莨菪貼劑的使用
  • 改良東莨菪生產流程
• 市場問題
  • 與東莨菪鹼相關的副作用

波特的五力：駕馭東莨菪市場的策略工具

波特的五力架構是了解東莨菪市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解東莨菪市場的外部影響

外部宏觀環境因素在塑造東莨菪市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解東莨菪鹼市場的競爭狀況

對東莨菪市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：東莨菪市場供應商績效評估

FPNV定位矩陣是評估東紫星市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製東莨菪市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對東莨菪鹼市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 人們對使用東莨菪鹼作為暈車藥的認知有所提高
    • 旅客數量和國際觀光的增加
    • 東莨菪鹼可以當非處方藥嗎？
  • 抑制因素
    • 高成本和嚴格的監管通訊協定
  • 機會
    • 在手術期間和術後恢復期間增加經皮吸收貼片的使用
    • 改良東莨菪鹼生產流程
  • 任務
    • 與東莨菪鹼相關的副作用
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治
  • 經濟
  • 社會
  • 科技
  • 法律
  • 環境

第6章東莨菪鹼市場：依類型

• 介紹
• 丁溴東莨菪鹼
• 氫溴東莨菪鹼

第7章 東莨菪鹼市場：依管理方式分類

• 介紹
• 注射
• 口服
• 修補

第8章美洲東莨菪市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太東莨菪鹼市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東、非洲東莨菪市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• Alchem International Pvt. Ltd.
• Alkaloids Corporation
• Baxter International, Inc.
• C-Squared Pharma Sa RL
• Caleb Pharmaceuticals, Inc
• GlaxoSmithKline PLC
• Linnea SA
• Merck KGaA
• Morningside Healthcare Limited by Aspire Pharma Limited
• Myungmoon Pharm Co., Ltd.
• Perrigo Company PLC
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceuticals Industries Ltd.
• Wockhardt UK Limited

The Hyoscine Market was valued at USD 439.16 million in 2023, expected to reach USD 460.41 million in 2024, and is projected to grow at a CAGR of 4.66%, to USD 604.28 million by 2030.

Hyoscine, also known as scopolamine, is an alkaloid medication primarily used to treat motion sickness and postoperative nausea and vomiting. It is found in certain plants of the nightshade family and operates as an anticholinergic agent, blocking the neurotransmitter acetylcholine in the central and the peripheral nervous system. The necessity of hyoscine arises from its effectiveness in preventing nausea and its application extends to treatment of other conditions such as irritable bowel syndrome and muscle spasms, providing a multifaceted scope for the pharmaceutical industry. It is most commonly utilized in transdermal patch form, oral tablets, and intravenous injections, allowing widespread end-use in clinical settings, over-the-counter products, and emergency care. The market for hyoscine is significantly influenced by factors such as an increasing prevalence of motion sickness due to rising travel activities, expanding applications in gastrointestinal treatments, and ongoing research into neurodegenerative disease therapies. Opportunities lie in expanding the use in veterinary medicine, and formulating new delivery methods that enhance efficacy or reduce side effects. To capture these opportunities, investing in advanced R&D and collaboration with travel industry stakeholders is recommended, thereby enhancing product visibility and acceptance. However, growth is hindered by factors like stringent regulatory frameworks, potential side effects common to anticholinergics, including dry mouth, drowsiness, and blurred vision, and the competition from alternative therapies. Innovations may focus on developing hyoscine derivatives with higher selectivity, reducing adverse effects, and exploring potential use in cognitive disorders, such as Alzheimer's disease. The market is competitive yet promising, driven by expanding therapeutic applications and growing demand in emerging economies. Businesses must align their strategies to emerging consumer needs and regulatory landscapes to harness the full market potential of hyoscine.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyoscine Market

The Hyoscine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
  • Growing number of travelers and international tourism
  • Availability of hyoscine as over-the-counter medicine
• Market Restraints
  • High cost and stringent regulatory protocols
• Market Opportunities
  • Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
  • Improvements in production process of hyoscine
• Market Challenges
  • Side effects associated with hyoscine

Porter's Five Forces: A Strategic Tool for Navigating the Hyoscine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyoscine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hyoscine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyoscine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hyoscine Market

A detailed market share analysis in the Hyoscine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyoscine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyoscine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hyoscine Market

A strategic analysis of the Hyoscine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyoscine Market, highlighting leading vendors and their innovative profiles. These include Alchem International Pvt. Ltd., Alkaloids Corporation, Baxter International, Inc., C-Squared Pharma S.a R.L., Caleb Pharmaceuticals, Inc, GlaxoSmithKline PLC, Linnea SA, Merck KGaA, Morningside Healthcare Limited by Aspire Pharma Limited, Myungmoon Pharm Co., Ltd., Perrigo Company PLC, Pfizer Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., and Wockhardt UK Limited.

Market Segmentation & Coverage

This research report categorizes the Hyoscine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Hyoscine Butylbromide and Hyoscine Hydrobromide.
• Based on Mode of Administration, market is studied across Injections, Oral, and Patches.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
    • 5.1.1.2. Growing number of travelers and international tourism
    • 5.1.1.3. Availability of hyoscine as over-the-counter medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and stringent regulatory protocols
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
    • 5.1.3.2. Improvements in production process of hyoscine
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects associated with hyoscine
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hyoscine Market, by Type

• 6.1. Introduction
• 6.2. Hyoscine Butylbromide
• 6.3. Hyoscine Hydrobromide

7. Hyoscine Market, by Mode of Administration

• 7.1. Introduction
• 7.2. Injections
• 7.3. Oral
• 7.4. Patches

8. Americas Hyoscine Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Hyoscine Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Hyoscine Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alchem International Pvt. Ltd.
• 2. Alkaloids Corporation
• 3. Baxter International, Inc.
• 4. C-Squared Pharma S.a R.L.
• 5. Caleb Pharmaceuticals, Inc
• 6. GlaxoSmithKline PLC
• 7. Linnea SA
• 8. Merck KGaA
• 9. Morningside Healthcare Limited by Aspire Pharma Limited
• 10. Myungmoon Pharm Co., Ltd.
• 11. Perrigo Company PLC
• 12. Pfizer Inc.
• 13. Sanofi S.A.
• 14. Teva Pharmaceuticals Industries Ltd.
• 15. Wockhardt UK Limited

LIST OF FIGURES

• FIGURE 1. HYOSCINE MARKET RESEARCH PROCESS
• FIGURE 2. HYOSCINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HYOSCINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HYOSCINE MARKET DYNAMICS
• TABLE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE BUTYLBROMIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE HYDROBROMIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HYOSCINE MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HYOSCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HYOSCINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023